Why it was recalled
Failed Dissolution Specifications:
Product description
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Lot numbers, UPCs & expiration codes
Lot # 1012910, Exp Date: 04/30/2025
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0202-2025
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Dec 17, 2024
- FDA report date
- Jan 22, 2025
- Quantity
- 2,028 units (cartons of 30 individual unit doses)
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Amerisource Health Services LLC
Original FDA data
Every field from FDA enforcement report D-0202-2025, exactly as published.
Show all FDA fields
- City
- Columbus
- State
- OH
- Status
- Terminated
- Country
- United States
- Event ID
- 96033
- Address
- 2550 John Glenn Ave Ste A
- Code information
- Lot # 1012910, Exp Date: 04/30/2025
- Postal code
- 43217-1188
- Report date
- Jan 22, 2025
- Product type
- Drugs
- Recall number
- D-0202-2025
- Classification
- Class II
- Recalling firm
- Amerisource Health Services LLC
- Product quantity
- 2,028 units (cartons of 30 individual unit doses)
- Termination date
- Apr 16, 2026
- Reason for recall
- Failed Dissolution Specifications:
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Dec 17, 2024
- Initial firm notification
- Letter
- Center classification date
- Jan 16, 2025